The Middle EAST Gene Delivery System Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including increasing investments in gene therapy research, rising prevalence of genetic disorders, and advancements in delivery technologies. The demand for effective gene...